Justification RFO Part 12 (JandA) (JUNE 2025) Redacted.pdf
PDF 1 MB Posted
- Attached to
- Award Notice
- Solicitation number
- W81K0026QA155
- Issued by
-
Defense Health Agency
About this file
This is a FAR Part 12 Justification and Approval for Simplified Procedures for Certain Commercial Items, documenting a single-source procurement by the Medical Readiness Contracting Office-West for the Department of Radiology Nuclear Medicine Clinic at WBAMC, Fort Bliss, Texas.
The procurement concerns radiopharmaceuticals required for imaging and therapeutic treatment of cancer patients. The products must be prepared in a USP 825 compounding environment and delivered 24 hours daily, 365 days per year on an as-needed basis. The contract is structured as a two-year firm-fixed-price definitive contract (base plus one option year) with an estimated overall total price of redacted amount, funded through Defense Health Program appropriations. Market research conducted on May 19, 2026 queried the SBA database using NAICS code 325412 and keywords including "radiopharmaceuticals," "lymphoseek," "Illuccix," and "Technetium," revealing no small businesses capable of providing the required items. A DLA Medical Master Catalog search confirmed unavailability through standard supply channels. A sources sought notice posted to SAM.gov on April 24, 2026 (closing May 8, 2026) generated responses from two vendors. The justification identifies geographic and operational constraints requiring a supplier within a critical 50-mile radius to support just-in-time delivery of short half-life isotopes. The Government determined no alternative sources exist capable of meeting requirements and certified inability to procure technical data or breakout components for full and open competition. The J&A will be posted within 14 days after contract award, subject to fund availability.
View the file
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Control Number:
Reviews: I have reviewed this justification and find it adequate to support other than full and open competition.
Control Number:
CUI//SP-
JUNE 2025
critical 50-mile operational threshold necessary to support just-in-time delivery of short half-life isotopes.
can deliver the required radiopharmaceuticals 24 hours a day, 365 days a year.
c. Impact if not approved:
7. Efforts to Obtain Competition:
a. Effective competition: Based on market research and the results of the sources sought and notice of intent, competition is not anticipated for this requirement. The J&A will be posted within 14 days after co ract award.
b. Subcontracting competition:
8. Actions to Increase Competition:
“Actions to Increase Competition” stated: “Future competition will be based on the timeliness of the submission of procurement packets of radiopharmaceuticals and cold kits.
Additionally, an evaluation of the market will be conducted prior to any renewal related to this requirement.
Those actions were accomplished, and no other source was found who can meet the Government’s requirements. The Government is unable to procure the technical data or breakout subsystems or components for full and open competition.
9. Market Research: In accordance with
Specifically, on 19 May 2026, the Small Business
Administration (SBA) database was queried using NAICS code 325412 alongside keywords including "radiopharmaceuticals," "lymphoseek," "Illuccix," and "Technetium." The results of this search, a copy of which is retained in the Paperless Contract File (PCF), revealed that there are no small businesses within any socioeconomic category capable of providing the required radiopharmaceuticals.
Additionally, a Defense Logistics Agency (DLA) Medical Master Catalog (MMC) was searched on 19 May 2026 and confirmed that these specialized items are unavailable
A
File details come from the government source that posted it. Updated .